Ovarian Cancer
Next Phase of Early Cancer Detection Alliance to Focus on Hereditary Cancers, Disease Interception
Premium
One ACED project is focused on developing biomarkers for the early detection of ovarian cancer, with the goal of commercializing any resulting tests.
MRC Holland Gets CE-IVDR Certification for Breast, Ovarian Cancer Syndrome Tests
The Amsterdam-based company recently received IVDR certification for other tests including one for phenylketonuria.
Aspira Receives Delisting Notice, Announces Plans to Appeal the Decision
The firm received notice that it had failed to regain compliance with the Nasdaq's requirement to maintain a minimum $35 million market value of listed securities.
The McGill University team is advancing a test, dubbed DOvEEgene, which sequences DNA from a uterine brush sample to detect cancer-associated mutations.
Roche IHC Assay Nabs CE Mark as Companion Diagnostic for Abbvie's Elahere in Ovarian Cancer
The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.